ASCO/EHA/ICML 2023 – Anna Schuh
Anna Schuh talks about genetic aberrations in subclones in terms of the molecular dynamics of relapse in patients with CLL, the benefits of liquid biopsies as well as the current role and future application of whole-genome sequencing in precision hematology while ultimately depicting her personal highlights from this year’s EHA congress.
Here is the full ASCO/EHA/ICML 2023 report.
More posts
DLBCL: treatment of elderly patients and relapsed disease
DLBCL: treatment of elderly patients and relapsed disease POLAR BEAR: novel regimen fr
Waldenström macroglobulinemia: findings from ASPEN and BRUIN
Waldenström macroglobulinemia: findings from ASPEN and BRUIN ASPEN: HRQoL for zanubrut
Outcome improvements in relapsed and untreated marginal zone lymphoma
Outcome improvements in relapsed and untreated marginal zone lymphoma Final analysis o
Follicular lymphoma: study results with bispecific antibodies and BTK inhibitors
Follicular lymphoma: study results with bispecific antibodies and BTK inhibitors Mosun
Current insights into BTK inhibition and other targeted approaches in CLL
Current insights into BTK inhibition and other targeted approaches in CLL Treatment-na
Preface – ASCO/EHA/ICML 2023
Preface – ASCO/EHA/ICML 2023 © Dirk Gillissen – Arnon P. Kater, MD, PhD, Department o
